Table 2.
Incidence of major events according to clopidogrel response status and renal function
| Major Events within Follow-up (n) (%) | Low-Responder Group 1 (n = 165) | Responder Group 1 (n = 396) | P | Low-Responder Group 2 (n = 161) | Responder Group 2 (n = 613) | P |
|---|---|---|---|---|---|---|
| First combined major event within follow-up | 30 (18.2) | 46 (11.6) | 0.038 | 11 (6.8) | 35 (5.7) | 0.59 |
| Myocardial infarctiona | 17 (10.2) | 20 (5.1) | 0.024 | 9 (5.7) | 21 (3.4) | 0.20 |
| Ischemic strokea | 2 (1.2) | 16 (4.1) | 0.08 | 1 (0.6) | 6 (1.0) | 0.67 |
| Deatha | 17 (10.3) | 22 (5.6) | 0.04 | 3 (1.9) | 10 (1.6) | 0.85 |
aThe numbers do not sum up to a total combined event rate because of multiple occurrences of major events within follow-up in some patients.